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Abstract
Background: We investigated the use of a simple novel nut and bolt task in premanifest and manifest 
Huntington’s disease (HD) patients to detect and quantify motor impairments at all stages of the disease.
Methods: Premanifest HD (n=24), manifest HD (n=27) and control (n=32) participants were asked to screw 
a nut onto a bolt in one direction, using three different sized bolts with their left and right hand in turn.
Results: We identified some impairments at all stages of HD and in the premanifest individuals, deficits in 
the non-dominant hand correlated with disease burden scores.
Conclusion: This simple, cheap motor task was able to detect motor impairments in both premanifest and 
manifest HD and as such might be a useful quantifiable measure of motor function for use in clinical 
studies.
INTRODUCTION
Huntington’s disease (HD) is an autosomal dominant condition causing neurodegeneration of the cortex
white matter  and basal ganglia . This leads clinically to motor deficits including chorea, 
bradykinesia, and dystonia as well as cognitive deficits, circadian rhythm disturbances and psychiatric 
problems . The ability to robustly detect early motor impairments in HD using a simple cheap test is 
needed to provide an objective quantifiable measure of motor performance that is useful both clinically and 
as an endpoint in therapeutic trials, and which can be followed over time. Also more tests that measure 
everyday motor tasks that impact on functional independence as the disease progresses are required. As 
such, many groups, including our own, have sought to develop motor tasks to detect and track early 
changes in premanifest HD (preHD)  including both the finger  and hand tapping tests 
Motor differences are not just seen in tapping tasks, as other studies have shown that there are changes in 
the variability of grip force in a grasping task in HD patients ; a reduction in tongue force in preHD 
patients ; a reduction of speech rate in motor speech tasks  and impairments in saccade latency and 
velocity in HD . Furthermore these simple tasks have been correlated to structural brain changes in 
HD and preHD  as well as cognitive deficits . Other more complex motor tasks such as those involving 
diadochokinetic movements  and peg insertions, whilst able to detect impairments in manifest disease are 
insensitive during preHD . Many of these tasks described require specialized equipment and complicated 
analysis. In this paper we have assessed participants with manifest HD and preHD using a very simple and 
cheap nut and bolt test which has previously been used to look at the effects of extravehicular activity 
(EVA) gloves on dexterity, grip force and coordination in healthy participants . This new test is ideal for 
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use in HD given its ecological validity, its ease of administration and the fact that it is so inexpensive; this 
makes it accessible for use in any population of HD patients and it doesn’t require any specialised custom 
computer software to interpret the results collected. To examine the validity of this new motor task, we 
tested a large group of individuals at pre-manifest and manifest stages of HD compared to healthy controls. 
Finally, we examined whether performance on this timed nut and bolt test was related to disease burden 
score (DBS). We now report for the first time that this simple inexpensive test can detect the earliest motor 
abnormalities in HD and performance correlates with disease burden scores across the entire disease, and 
so could be used to target those patients on the cusp of developing overt disease and as such may be 
suitable for use in new trials of disease modifying therapy.
METHODS
Participants
Participants were recruited from the regional NHS HD clinic at the John Van Geest Centre for Brain Repair 
between 2012 and 2014. Control subjects with no known neurological disease were recruited from friends 
or relatives accompanying patients to the clinic. Written informed consent was taken and the nut and bolt 
data was collected under ethical approval [Reference number:09/H0308/2] approved by Cambridgeshire 2 
Research Ethics Committee. To collect additional data the task was also expanded to include patients seen 
in clinic as part of their routine clinical assessment and the collection of this data was classified as a service 
evaluation with the Patient Safety Unit at Addenbrooke’s Hospital (Project Register Number: 4256). The 
work was carried out in accordance with the World Medical Association Declaration of Helsinki . All 
preHD and HD participants had a positive genetic test for the HD mutation and were assessed using the 
UHDRS motor examination along with their total functional capacity (TFC) sub-section . PreHD 
participants were defined by having a diagnostic confidence level on the UHDRS of less than 4. Disease 
burden score was calculated using the CAG-Age Product Scale (CAPS) .
Nut and bolt task
The nut and bolt task was designed as a simple test to examine dexterity of the hands and fingers. The 
participants were asked to screw a nut onto a bolt in one direction using either the left or right hand; 
participants were not allowed to flick the nut and the hand holding the bolt had to remain static/stationary. 
The task consisted of 3 different sized nuts and bolts and was timed for both hands for all conditions. The 
task was performed using two test conditions; while the hands were supported resting on a table or 
unsupported, with the hands held in mid air. The task was timed using a standard stopwatch, the timer was 
started when the participant began screwing the nut onto the bolt and the timer was stopped when the nut 
reached the top of the bolt and could go no further. All those administering this test were instructed in how 
to carry out the test, but the simplicity of the task and the use of a simple stopwatch meant that no extensive 
training was needed.
Statistics
Statistical analysis was performed using IBM SPSS software version 21.0. The main outcome for the task 
was the time it took for each participant to screw the nut onto the bolt using the left and right hand 
sequentially, both supported and unsupported. The independent variables were the three groups (Controls, 
PreHD, HD). Normality for all the dependent variables was tested using one-sample Kolmogorov-Smirnov 
tests. Group effects for variables that were normally distributed, such as age, CAG repeat, and UHDRS 
motor score were analysed using parametric tests (ANOVA) followed by post-hoc comparisons (T-test) 
with Bonferroni corrections where significance was present, all p values reported in the manuscript are 
already corrected. The group main effect was found to be significant. Variables with a skewed distribution, 
including data obtained from the nut and bolt assessments were first logarithmically transformed to obtain 
normality and analysed as above with the exception of the total functional capacity scores which were 
analysed using Mann-Whitney U tests. Partial Spearman correlations were performed using age as a 
covariate.
RESULTS
Participant demographics
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A total of 83 participants were tested on this task and were divided into 3 groups: healthy controls, preHD 
and manifest HD participants (See table 1). As would be expected, manifest HD participants had a higher 
UHDRS total score [p < 0.001] and a lower TFC score [p < 0.001] than preHD participants. Healthy 
controls and preHD participants displayed similar baseline demographics (age) [p = 0.863], while 
participants with manifest HD were slightly older than control participants [p = 0.004] (Table 1).
Table 1. Table shows mean ± S.E.M. UHDRS: Unified Huntington’s Disease Rating Scale: total motor 
score, TFC: total functional capacity. *indicates statistically significant difference when compared to 
controls whereas # indicates statistically significant difference when compared to preHD.PreHD 
participants show impaired performance in their performance with the non-dominant hand compared to 
controls.
PreHD participants show impairments in their performance with the non-dominant hand compared 
to controls.
PreHD participants were impaired on several aspects of the nut and bolt task when compared to the healthy 
controls, particularly when the non-dominant hand was being tested. Significant changes were observed 
with all sizes of the nut and bolt when the non-dominant hand was in the unsupported condition [small: p = 
0.036. medium: p = 0.006 large: p = 0.001, table 2] and the large nut and bolt when the non-dominant hand 
was supported [p = 0.034]. In contrast, only one measurement was significantly different when testing the 
dominant hand [medium, unsupported: p = 0.009] indicating that dominant hand function is relatively well 
preserved at this stage of the condition (Table 2).
Anti-dopaminergic medication has no effect on performance on the nut and bolt task.
Anti-dopaminergic medications such as sulpiride and olanzapine are commonly used for treating the motor 
features of HD and hence may have an effect on performance in the nut and bolt task. In order to analyse 
the effect of such medications, we divided the preHD and HD participants into those who were receiving 
anti-dopaminergic medications and those who were not. Due to the nature of prescribing such medication 
for symptomatic relief of the motor features of HD, patients who were receiving such medication were in a 
more advanced stage of disease and hence were significantly older and a higher total motor score on the 
UHDRS [TMS: t = 3.29, p = 0.002, Age: t = 2.85, p = 0.006]. Therefore in order to minimise such 
confounding facts we included age and the total motor score as covariates in our analysis. Our results 
showed that there was no statistically significant difference in motor performance between those receiving 
anti-dopaminergic medication and those who were not [F = 1.75, p > 0.111].
Manifest HD patients are significantly impaired in all domains of the nut and bolt task
Compared to controls the manifest group performed worse on all conditions tested while the preHD group 
appeared to demonstrate deficits under specific conditions (Table 2). In particular, whereas dominant hand 
function was not significantly different when comparing preHD to controls, manifest HD participants 
showed impairments compared to preHD when the dominant hand was tested with the small and medium 
nut and bolts whilst supported [small: p = 0.002, medium: p = 0.021] and the small and large nut and bolts 
whilst unsupported [small: p = 0.02, large: p = 0.006]. Performance with the small nut and bolt using the 
unsupported non dominant hand is significantly impaired at all stages of disease [preHD compared to 
controls: p = 0.036, HD compared to preHD: p = 0.032] (Figure 1) and correlates significantly with disease 
burden score (r=0.374), even when controlled for age [p = 0.021] (Figure 2). Finally all components of the 
nut and bolt task correlated with the patients UHDRS score in both preHD and manifest patients [small 
non-dominant unsupported nut and bolt: r = 0.494, p = 0.001].
Discussion
The ability to detect, quantify and follow the loss of hand dexterity in HD is of importance for diagnosing 
patients at the earliest stages of disease, monitoring disease progression and evaluating the efficacy of 
novel treatments. Previous tests that have been proposed to be useful in this regard include finger  and 
hand tapping  with both tasks tracking disease course over time . However, while they 
capture changes in motor speed they do not measure changes in dexterity. In our new study, we introduced 
a novel task: the nut and bolt test, which we have now shown to be a useful way of measuring the impact of 
HD on fine motor coordination in a large group of patients. In particular, we have found significant 
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differences in performance between preHD and controls in their non dominant hand with the dominant 
hand function remaining intact until later in the disease course. Furthermore the non dominant nut and bolt 
performance correlated with disease burden scores suggesting a relationship with proximity to disease 
onset. Therefore, the nut and bolt task may be both diagnostically useful and helpful for identifying 
premanifest patients at immediate risk of developing manifest disease who may also therefore be suitable 
for future trials of disease modifying therapy.
This finding of decreased performance in the non dominant hand is in agreement with the existing 
literature; specifically the TRACK-HD study that showed that there is a reduction in finger tapping in the 
non dominant hand over time . In the cohort of premanifest and early HD patients, it was found that 
tapping was one of the few functional measurements that had significant differences in preHD participants 
compared to controls and also progressed over time . Previously, differences in performance on simple 
speed tapping tasks in preHD and early stage HD cohorts have been correlated with cortical thickness, 
disease burden scores and motor scores  and in another study manifest and early HD patients tapping 
scores correlated with cognitive test scores, regional brain atrophy and UHDRS scores . All of which 
highlights that these simple motor measures are useful measures of disease stage with a pathology that can 
also be quantified.
Other motor tasks that have also be used in a similar way in HD include saccadic eye movements in which 
it has been shown that preHD patients can have a number of abnormalities that seem to track disease course 
over time . Quantitative measurements of tongue protrusion force in preHD and HD have also detected 
deficits in motor force  and in motor speech timing tasks in manifest HD patients showing impaired 
speech rhythm with defects in speech rate, increased pauses, impaired syllable repetition all of which 
correlated with motor tapping assessments . Other studies have shown slowing of rapid alternating 
movements in HD patients, as well as deficits in tapping and on peg insertion tasks . This confirms earlier 
findings where the peg insertion task was significantly different in HD patients compared to controls but 
failed to detect early changes in preHD groups . These tasks along with our simple task may suggest that 
the combination of speed and simple movements may highlight early deficits in HD, especially in the less 
dextrous non dominant hand. Indeed our nut and bolt task is unique in that is takes into account speed, 
dexterity, hand movements and motivation and as such may be more sensitive to the very earliest problems 
in HD which effects all of these functions. This would fit with imaging and post mortem data showing that 
those brain regions involved in these motor and affective activities are known to be abnormal in preHD and 
early HD including the striatum  the nucleus accumbens, pallidum  precentral and postcentral 
gyri as well as the supplementary motor area . Thus the clinical data sits well with the known 
neuropathology of premanifest and early HD.
Although, our test has many advantages including its cost and ease of administration and simple 
interpretation of results there are also some limitations with our study . This includes the absence of 
longitudinal data, and the need to trial it in larger numbers of patients and the problems of employing it in 
very advanced patients. However, this latter group are unlikely to be the target of new therapeutic 
interventions in the first instance, so this is less of an issue. Furthermore the nut and bolt task was timed 
manually using a standard stop watch and although the timing was not automated, each individual was 
trained in the same way and thus is unlikely to have contributed to any significant issues on the accuracy of 
the data collection. However using an automated timer may be a useful addition to our task. Finally our 
study captured a selection of un-medicated and medicated preHD and HD patients seen in our regional 
clinic, including HD patients on anti-dopaminergic medication such as sulpiride and olanzapine. Although 
we found no significant difference in our task in those patients on anti-dopaminergic medications compared 
to those who were not, we cannot rule out that this may effect their performance. In the future longitudinal 
studies that specifically address this issue are needed.
In summary, we describe a simple, inexpensive and robust task that is useful in defining disease onset as 
well as being of possible value in therapeutic trials of disease modifying therapies in both manifest patients 
and pre-HD patients approaching the time of phenoconversion. Furthermore it can be used in any clinic on 
its own or as part of a battery of tests to assess dexterity across all stages of HD given its simplicity and low 
cost.
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Table 1:Demographic and clinical characteristics of study participants.
Group Age CAG UHDRS TFC
Premanifest (n=24) 47.47 ± 2.66 41.73 ± 0.662 3.87 ± 0.975 12.26 ± 0.492
Manifest (n=27) 56.30 ± 2.62* 43.74 ± 0.796 24.07 ± 2.28# 8.78 ± 2.28#
Controls (n=32) 43.08 ± 3.18 - - -
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Table 2: Median times for each group to complete nut and bolt task; for all task conditions
Median (Seconds) p values
Controls PreHD HD Control-PreHD PreHD-HD Controls-HD
Non Dominant Supported Small 24 29 37 0.435 0.024 <0.001
Medium 19 25 31 0.076 0.04 | 0.001
Large 14.5 24 21 0.034 0.093 <0.001
Unsupported Small 19 25 36 0.036 0.032 <0.001
Medium 14.5 23 30 0.006 0.198 <0.001
Large 10 19 23.5 0.001 0.235 <0.001
Dominant Supported Small 23 25 43.5 0.152 0.002 <0.001
Medium 19.6 23 35.5 0.122 0.021 <0.001
Large 17.5 20 29 0.559 0.084 <0.01
Unsupported Small 21 22 36.5 0.239 0.02 <0.001
Medium 16.5 21 32 0.009 0.052 <0.001
Large 13 15 26.5 0.14 0.006 <0.001
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Non dominant unsupported hand measurements of time to complete small nut and bolt 
test for each group.
Unsupported small nut and bolt in the non dominant hand in each group. Significance is denoted by asterisks, preHD 
compared to controls: p = 0.036, HD compared to preHD: p = 0.032.
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Small nut and bolt measurement correlates with Disease Burden Score.
The time taken for the non dominant unsupported hand to complete the small nut and bolt task correlates with disease 
burden score [r = 0.374, p = 0.021]. Correlation is significant at the 0.05 level (2-tailed).
Articles from PLoS Currents are provided here courtesy of Public Library of Science
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